Asters Advises on Ukrainian Merger Control Aspects of approx. USD 5.4 Billion Acquisition of Novartis' Animal Health Business by Eli Lilly

Asters provided legal advice to the global healthcare leader Eli Lilly and Company on Ukrainian merger control law issues, including obtaining merger and antitrust clearances from the Ukrainian competition authority for the approx. USD 5.4 billion acquisition by Eli Lilly and Co. of Novartis' Animal Health business.

The transaction is aimed to strengthen and diversify Eli Lilly's own animal health unit. Upon completion of the acquisition, Elanco will become the second-largest animal health company in terms of global revenue.

Asters team advising on the project included Igor Svechkar, Sergiy Glushchenko, Anastasia Usova, and Igor Smolyak.

Thank you for your application
This site uses cookies to offer you better browsing experience.
Toggle high contrast
Toggle normal contrast
Toggle big fonts
Toggle normal fonts